Author:
Liu Fen,Wang Xiwei,Wei Fang,Hu Huaidong,Zhang Dazhi,Hu Peng,Ren Hong
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference43 articles.
1. Dienstag JL: Benefits and risks of nucleoside analog therapy for hepatitis B. Hepatology 2009, 49: S112-S121. 10.1002/hep.22920
2. Fung J, Lai CL, Seto WK, Yuen MF: Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. J Antimicrob Chemother 2011, 66: 2715-2725. 10.1093/jac/dkr388
3. Ghany MG, Doo EC: Antiviral resistance and hepatitis B therapy. Hepatology 2009, 49: S174-S184. 10.1002/hep.22900
4. Qiu YW, Jiang XH, Huang LH, Hu TH, Ding H, Jiang YM, Dai YX, Zhou M: A study on the treatment of chronic hepatitis B with YMDD mutation. Zhonghua Gan Zang Bing Za Zhi 2009, 17: 171-174.
5. Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, Hunt C, Brown N, Woessner M, Boehme R, Condreay L: Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis 2003, 36: 687-696.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献